Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

GlaxoSmithKline presents new compounds for HIV infections

May 23, 2019

Celgene presents results from phase I APHRODITE study of CC-11050

May 22, 2019

New phase I trial studies MK-8558 in antiretroviral-naive patients with HIV-1

May 16, 2019

Surfactant protein D restricts HIV-1 passage across vaginal barrier in preclinical models

May 16, 2019

NIH initiates LATITUDE study to evaluate long-acting HIV medication

May 13, 2019

CytoDyn reports data from leronlimab monotherapy study

May 7, 2019

Gilead Sciences divulges new HIV protease inhibitors

May 7, 2019

NIAID initiates phase I study of a trispecific broadly neutralizing antibody against HIV

May 6, 2019

FDA approves Dovato for treatment-naive HIV-1

April 9, 2019

Human TRIM5-alpha active against HIV

March 28, 2019

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...